↓ Skip to main content

90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

Overview of attention for article published in Journal of Clinical Oncology, March 2010
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs
2 blogs
policy
1 policy source
patent
1 patent
wikipedia
2 Wikipedia pages
guideline
5 clinical guideline sources

Readers on

mendeley
93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Germany 2 2%
Korea, Republic of 1 1%
United Kingdom 1 1%
Unknown 89 96%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 19 20%
Student > Bachelor 10 11%
Student > Doctoral Student 9 10%
Student > Master 9 10%
Other 8 9%
Other 18 19%
Unknown 20 22%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 46 49%
Nursing and Health Professions 4 4%
Agricultural and Biological Sciences 4 4%
Psychology 4 4%
Neuroscience 3 3%
Other 8 9%
Unknown 24 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2021.
All research outputs
#1,407,059
of 32,375,021 outputs
Outputs from Journal of Clinical Oncology
#3,844
of 29,905 outputs
Outputs of similar age
#4,450
of 134,588 outputs
Outputs of similar age from Journal of Clinical Oncology
#21
of 190 outputs
Altmetric has tracked 32,375,021 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 29,905 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.6. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 134,588 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 190 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.